The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
From bench to bedside: The use of the li-Key technology to improve helper peptides for clinical use in cancer vaccines.
Timothy J Vreeland
No relevant relationships to disclose
Diane F Hale
No relevant relationships to disclose
Alan K. Sears
No relevant relationships to disclose
Guy T. Clifton
No relevant relationships to disclose
Efi Pappou
No relevant relationships to disclose
Raetasha Sheavette Dabney
No relevant relationships to disclose
Alexandros Ardavanis
No relevant relationships to disclose
Ritesh Patil
No relevant relationships to disclose
Sathibalan Ponniah
No relevant relationships to disclose
Eleftheria Anastasopoulou
No relevant relationships to disclose
Sonia A. Perez
No relevant relationships to disclose
Nathan M. Shumway
No relevant relationships to disclose
George Earl Peoples
Consultant or Advisory Role - Antigen Express (U)
Elizabeth Ann Mittendorf
Research Funding - Antigen Express